T2DM is a complex heterogeneous group of metabolic disorders including hyperglycemia and impaired insulin action and/or insulin secretion, and a detailed etiology underlying T2DM is still unclear [58,59]. This evidence concerns the gene INS and type 2 diabetes mellitus.